TickerFactsScreenerDevelopers

ADMA BIOLOGICS, INC. (ADMA) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2011: $2702012: $118.9K2013: $196.6K2014: $2.32M2015: $26.1K2016: $73.4K2017: $2.68M2018: $2.10M2019: $3.81M2020: $12.73M2021: $13.51M2022: $13.91M2023: $4.77M2024: $8.23M2025: $22.57M$22.57M
2011Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$22.57M+174.4%
2024$8.23M+72.4%
2023$4.77M-65.7%
2022$13.91M+3.0%
2021$13.51M+6.2%
2020$12.73M+233.9%
2019$3.81M+81.9%
2018$2.10M-21.7%
2017$2.68M+3545.7%
2016$73.4K+181.6%
2015$26.1K-98.9%
2014$2.32M+1081.5%
2013$196.6K+65.4%
2012$118.9K+43919.6%
2011$270—